Hair Loss

 

Hair loss (alopecia) can be, but is not always, a side effect of certain chemotherapy drugs. Your health care team will tell you before you start treatment whether you can expect to lose your hair. Hair loss typically begins 2 or 3 weeks after chemotherapy treatment starts.

You may experience thinning or loss of hair on your head, underarms, and leg, and the loss or reduction of your eyebrows, eyelashes, facial hair, and pubic hair. The amount of hair you lose is related to the type of chemotherapy you receive. The good news is that your hair will grow back—typically 1 to 2 months after chemotherapy ends. It may take 6 months or more for your hair to fully grow back.

It can be difficult to prepare yourself for the loss of your hair. This change in your self-image is often a visual reminder to you and others that you are undergoing treatment for cancer. It’s OK to allow yourself to grieve the loss of your hair. Encourage family members, especially children, to express their thoughts and emotions about your hair loss. Remember, losing your hair does not change who you are as a person. You are still you.

Tips for Dealing with Hair Loss

  • Get a short haircut before you begin treatment. It may help you adjust to and manage the loss.
  • Shop for a wig before your hair is gone, especially if you wish to match your natural color. (Be sure to ask your insurance company if it covers the cost of a wig.)
  • Be gentle with your hair. Use mild shampoos and soft hair brushes. Avoid chemicals, including bleach, peroxide, or hair dye.
  • Remember to cover your head or use sunscreen (with an SPF of at least 15) on your scalp. Your skin may be particularly sensitive to ultraviolet (UV) rays.
  • Shaving your head before your hair starts to fall out can give you a sense of control over your situation.
  • Besides wigs, try hats, scarves, and turbans. You may prefer these to a wig. Or you may decide not to cover your head at all. It’s up to you.
  • There are programs that teach makeup and accessorizing techniques to cancer patients. Ask your health care team for information.
This content was last modified on August 29, 2007 .
Latest Cancer News
Vaccine Against HPV-16 Effective for Vulvar Intraepithelial Neoplasia

November 6, 2009 — Researchers from the Netherlands have reported that vaccination with synthetic long-peptides against human papillomavirus (HPV)-16 was effective in treating vulvar intraepithelial neoplasia (VIN). The details of this study were published in the November 5, 2009 issue of the New England Journal of Medicine.

Small HER2-positive Breast Cancers Have a Higher Risk of Recurrence

November 6, 2009 — Researchers from the M. D. Anderson Cancer Center and the University of Milan, Italy, have reported that women with Stage T1a,b, N0M0 HER2-positive breast cancers have a have a high recurrence rate without the administration of adjuvant chemotherapy or Herceptin® (trastuzumab). These data suggest that these women should be treated with Herceptin®-based adjuvant chemotherapy. The details of these two studies appeared in early online publications on November 2, 2009 in the Journal of Clinical Oncology.

Alcohol May Reduce Risk of Thyroid Cancer

November 6, 2009 — Researchers affiliated with the NIH-AARP Diet and Health Study have reported that alcohol intake may reduce the risk of thyroid cancer. The details of this study appeared in the November 4, 2009 issue of the British Journal of Cancer.

Select news items provided by Reuters Health